Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical company, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, have signed a drug discovery research collaboration to jointly discover and develop novel treatments to address unmet medical needs in a specific neurological disease.   Under the agreement, twoXAR will use its AI technology to identify a set of lead compounds which demonstrate a novel mechanism of action and will be further optimized by Ono for p...